TD Cowen Forecasts Strong Price Appreciation for MKS (NASDAQ:MKSI) Stock

MKS (NASDAQ:MKSI) had its price target upped by analysts at TD Cowen from $200.00 to $230.00 in a research report issued on Thursday. The brokerage currently has a “buy” rating on the scientific and technical instruments company’s stock. TD Cowen’s price objective would indicate a potential upside of 4.20% from the company’s previous close.

MKSI has been the topic of a number of other reports. Needham & Company LLC lifted their price objective on MKS from $210.00 to $260.00 and gave the company a “buy” rating in a research report on Thursday. Deutsche Bank Aktiengesellschaft set a $175.00 price target on shares of MKS and gave the company a “buy” rating in a report on Friday, October 31st. Mizuho set a $215.00 price objective on shares of MKS in a research note on Friday, January 9th. KeyCorp raised their price objective on shares of MKS from $180.00 to $250.00 and gave the company an “overweight” rating in a research report on Friday, January 16th. Finally, Cantor Fitzgerald lifted their target price on shares of MKS from $200.00 to $300.00 and gave the company an “overweight” rating in a research note on Tuesday. Ten research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $208.42.

MKS Trading Up 4.8%

Shares of MKSI stock opened at $220.73 on Thursday. The company has a debt-to-equity ratio of 1.64, a current ratio of 2.86 and a quick ratio of 1.81. The company has a market cap of $14.83 billion, a price-to-earnings ratio of 53.58, a PEG ratio of 1.94 and a beta of 1.92. MKS has a 1 year low of $54.84 and a 1 year high of $221.07. The firm has a fifty day moving average price of $166.29 and a 200-day moving average price of $134.80.

MKS (NASDAQ:MKSI) last released its earnings results on Wednesday, November 5th. The scientific and technical instruments company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.80 by $0.13. MKS had a return on equity of 20.80% and a net margin of 7.25%.The company had revenue of $988.00 million for the quarter, compared to the consensus estimate of $963.87 million. During the same period in the previous year, the business earned $1.72 earnings per share. MKS’s quarterly revenue was up 10.3% compared to the same quarter last year. MKS has set its Q4 2025 guidance at 1.930-2.610 EPS. As a group, equities analysts predict that MKS will post 6.94 earnings per share for the current year.

Insiders Place Their Bets

In other MKS news, Director Elizabeth Mora sold 300 shares of MKS stock in a transaction on Tuesday, December 2nd. The shares were sold at an average price of $158.81, for a total value of $47,643.00. Following the sale, the director directly owned 18,963 shares in the company, valued at approximately $3,011,514.03. The trade was a 1.56% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.57% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in MKSI. USA Financial Formulas purchased a new position in MKS during the 4th quarter valued at approximately $26,000. SJS Investment Consulting Inc. purchased a new stake in shares of MKS during the 3rd quarter worth approximately $30,000. Smartleaf Asset Management LLC boosted its position in shares of MKS by 74.5% during the 3rd quarter. Smartleaf Asset Management LLC now owns 260 shares of the scientific and technical instruments company’s stock valued at $32,000 after acquiring an additional 111 shares during the last quarter. Danske Bank A S purchased a new position in shares of MKS in the third quarter valued at $37,000. Finally, Winnow Wealth LLC purchased a new position in shares of MKS in the third quarter valued at $38,000. Institutional investors own 99.79% of the company’s stock.

About MKS

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.